: CRISIL Ratings - The Most Reliable Opinion on Risk :
CRISIL Ratings -Baby Memorial Hospital Ltd
March 09, 2010
Mumbai
CRISIL downgrades rating on BABY MEMORIAL HOSPITAL
to ‘B/Stable’
Rs.600.00 Million Long-Term Loan B/Stable (Downgraded from ‘B+/Stable’)

CRISIL has downgraded its rating on the long-term loan of Baby Memorial Hospital Ltd (BMHL) to ‘B/Stable’ from ‘B+/Stable’. The downgrade reflects the weakening of BMHL’s financial risk profile because of cost overruns following a delay of nine months in its on-going project of setting up a 300-bed super speciality hospital; the hospital will be housed in an annexe to the current hospital building. The downgrade also reflects CRISIL’s expectation of further stress on BMHL’s financial risk profile, as the company is likely to expend Rs.290 million more, which were not planned earlier, because of a change in the project plan. This additional capex will be largely funded through debt. The downgrade also factors in BMHL’s aggressive capex plans of Rs.4.75 billion for setting up more hospitals over the next two years. CRISIL believes that the financial risk profile of BMHL will be constrained, over the medium term, if there is no substantial equity infusion into the company.

The ratings reflect BMHL’s weak financial risk profile marked by weak debt protection measures, and high gearing, project implementation risks, and exposure to limitations of single-location operations. These weaknesses are partially offset by BMHL’s established position in the Calicut market, and mitigation of employee attrition risks.

Outlook: Stable
CRISIL believes that BMHL will continue to benefit from its established market position. However, the company’s financial risk profile will remain under pressure over the medium, if there is no fresh large equity infusion into the company. The outlook may be revised to ‘Positive’ if there is substantial equity infusion into the company, thereby mitigating the funding risk for its capex and improving its capital structure. Conversely, the outlook may be revised to ‘Negative’ if BMHL faces further time or cost overruns in its ongoing capex programme or undertakes additional, large debt-funded capex programme, leading to deterioration in its capital structure.

About the Company
BMHL, started by Dr. K G Alexander in 1987 as a partnership-firm, is one of the largest hospitals in Calicut. The partnership-firm was converted into public limited company in April 2009. Currently, the hospital has 480 beds. The company is setting up a 300-bed super speciality unit, expected to commence commercial operations by June 2010. BMHL has positioned itself as a multi-speciality, tertiary care referral hospital, offers servicing in anaesthesiology and critical care, cardiology, neurosurgery, oncology, paediatrics, and cosmetology. BMH also offers post-graduate courses for doctors, and degree and diploma courses in nursing.

For 2008-09 (refers to financial year, April 1 to March 31), BMHL reported a profit after tax (PAT) of Rs.49.2 million on net sales of Rs.341.8 million, against a PAT of Rs.20.9 million on net sales of Rs.326.2 million for the previous year.

Media Contacts Analytical Contacts CRISIL Rating Desk
Mitu Samar
Head, Market Development & Communications
CRISIL Limited
Tel: +91-22- 3342 1838
Email: msamar@crisil.com

Tanuja Abhinandan
Market Development & Communications
CRISIL Limited
Tel: +91-22- 3342 1818
Email: tabhinandan@crisil.com
Gurpreet S Chhatwal
Director - CRISIL Ratings
Tel: +91-11-4250 5100
Email: gchhatwal@crisil.com

Subodh K Rai
Head - CRISIL Ratings
Tel: +91-11-4250 5100
Email: srai@crisil.com
Tel: +91-22-3342 3047 / 3342 3064
Email: CRISILratingdesk@crisil.com

Note:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution of its rationales for consideration or otherwise through any media including websites, portals etc.

CRISIL Complexity Levels are assigned to various types of financial instruments. The CRISIL Complexity Levels are available on www.crisil.com/complexity-levels. Investors are advised to refer to the CRISIL Complexity Levels for instruments that they propose to invest in. Investors can also call the CRISIL Helpline at +91 22 3342 3047 / + 91 22 3342 3064 with queries on specific instruments.


CRISIL is India's leading Ratings, Research, Risk and Policy Advisory company. CRISIL leverages its core strengths of credibility and analytical rigour to deliver opinions and solutions, that help clients mitigate and manage their business and financial risks, make markets function better, and help shape public policy. For more information, visit www.crisil.com.

Disclaimer: A CRISIL rating reflects CRISIL's current opinion on the likelihood of timely payment of the obligations under the rated instrument and does not constitute an audit of the rated entity by CRISIL. CRISIL ratings are based on information provided by the issuer or obtained by CRISIL from sources it considers reliable. CRISIL does not guarantee the completeness or accuracy of the information on which the rating is based. A CRISIL rating is not a recommendation to buy, sell, or hold the rated instrument; it does not comment on the market price or suitability for a particular investor. All CRISIL ratings are under surveillance. Ratings are revised as and when circumstances so warrant. CRISIL is not responsible for any errors and especially states that it has no financial liability whatsoever to the subscribers / users / transmitters / distributors of this product. CRISIL Ratings’ rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For the latest rating information on any instrument of any company rated by CRISIL, please contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (+91 22) 3342 3000.

March 09, 2010

http://www.crisil.com